Compositional Changes of B and T Cell Subtypes during Fingolimod Treatment in Multiple Sclerosis Patients: A 12-Month Follow-Up Study

BACKGROUND AND OBJECTIVE: The long term effects of fingolimod, an oral treatment for relapsing-remitting (RR) multiple sclerosis (MS), on blood circulating B and T cell subtypes in MS patients are not completely understood. This study describes for the first time the longitudinal effects of fingolim...

Descripción completa

Detalles Bibliográficos
Autores principales: Claes, Nele, Dhaeze, Tessa, Fraussen, Judith, Broux, Bieke, Van Wijmeersch, Bart, Stinissen, Piet, Hupperts, Raymond, Hellings, Niels, Somers, Veerle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4215872/
https://www.ncbi.nlm.nih.gov/pubmed/25360562
http://dx.doi.org/10.1371/journal.pone.0111115

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4215872/
https://www.ncbi.nlm.nih.gov/pubmed/25360562
http://dx.doi.org/10.1371/journal.pone.0111115

Ejemplares similares